|
|
Volumn 13, Issue 10, 2014, Pages 717-
|
|
Trial watch: Next-generation antimalarial from phenotypic screen shows clinical promise
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATASE;
ANTIMALARIAL AGENT;
KAE 609;
NEW DRUG;
UNCLASSIFIED DRUG;
ANTIPROTOZOAL ACTIVITY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG TARGETING;
GENE;
GENE TARGETING;
GENETIC SCREENING;
HUMAN;
MALARIA;
MALARIA FALCIPARUM;
NONHUMAN;
PARASITE CLEARANCE;
PFATP4 GENE;
PHENOTYPE;
PHENOTYPIC PLASTICITY;
PLASMODIUM VIVAX MALARIA;
PRIORITY JOURNAL;
PUBLIC-PRIVATE PARTNERSHIP;
SHORT SURVEY;
|
|
EID: 84925953497
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4457 Document Type: Short Survey |
|
Times cited : (9)
|
|
References (0)
|
